Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07857070

Newborn Brain Assessment - CergenX Wave

Sponsor: CergenX Limited

View on ClinicalTrials.gov

Summary

In this study we want to assess how a newly developed software device called CergenX Wave compares to the modified Sarnat examination, performed by the neonatology team . The Wave software algorithm (which is a set of rules used by the computer) analyses EEG activity, using four electrodes placed on the neonate's scalp. A portable EEG machine records the EEG activity and a tablet will send this information to the cloud where the device analyses the data, as shown in the figure below. The EEG activity the Wave device evaluates will not be available to either the research or clinical team during the investigation but once the recording is completed the device will display a code on screen for the research team to confirm completion. The results will not be visible to either the researchers or the clinical team therefore will not in any way influence the care of the neonate. This is a regulated observational investigation to compare how the software performs against the current standard of care, a standardised neurological examination.

Official title: Determining Grade of Neonatal Encephalopathy - Agreement Between the Modified Sarnat Examination and Automated AI Assessment of Newborn Brain Function Using Wave Software

Key Details

Gender

All

Age Range

36 Weeks - Any

Study Type

OBSERVATIONAL

Enrollment

165

Start Date

2026-09

Completion Date

2027-09

Last Updated

2026-10-05

Healthy Volunteers

No

Interventions

DEVICE

CergenX Wave

The amplifier is used to acquire and transmit the EEG to the CergenX Wave software that is installed in a COTS computer.

Locations (2)

University of Texas Southwestern Medical Center

Dallas, Texas, United States

Cork University Maternity Hospital

Cork, Cork, Ireland